Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    Tregs | Diabetes
Show Display Options
Rank Status Study
1 Active, not recruiting T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs
Condition: Type 1 Diabetes Mellitus
Intervention: Biological: Ex vivo Expanded Human Autologous CD4+CD127lo/-CD25+ Polyclonal Regulatory T Cells
2 Not yet recruiting Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
Conditions: Diabetes Mellitus;   Malignant Neoplasm
Interventions: Procedure: assessment of therapy complications;   Other: laboratory biomarker analysis
3 Recruiting Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Dose D1 of interleukin-2;   Drug: placebo;   Drug: Dose D2 of Interleukin-2;   Drug: Dose D3 of interleukin-2
4 Completed Stem Cell Educator Therapy in Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Device: Stem Cell Educator

Indicates status has not been verified in more than two years